Corporate Sponsors

We are deeply grateful to our past and current corporate partners for supporting our mission to find a cure and improve the lives of those affected by ovarian and other gynecologic cancers.

Partner with us

Corporate Partners

Pharmaceutical Partners

Conflict of Interest Statement — Industry Partners

Corporate partners including industry do not shape OCRA’s agenda, research, or advocacy.
In 2023, industry partners represented 14% of OCRA’s overall revenue.
No industry personnel serve on OCRA’s governing board (Board of Directors).
If an industry partner sponsors an OCRA program, grant, or educational materials, it is publicly acknowledged and the supporting company has no editorial or strategic input.
Any reference to a specific commercial product or service does not constitute or imply an endorsement by OCRA of the product or service or its producer or provider. The views and opinions expressed in any referenced document or on any referenced website do not necessarily reflect those of OCRA.

Read our conflict of interest policy

Related Topics

OCRA’s Ovarian Cycle Tampa Fundraiser Recognized by ABC Action News Tampa

OCRA’s Ovarian Cycle Tampa marked its 12th year of raising funds and awareness for ovarian cancer research this past weekend, as reported by WFTS-TV ABC Action News Tampa Bay’s Robert … Continued

Harper’s Bazaar Honors the Legacy of Liz Tilberis, Our Organization’s First President

Harper’s Bazaar has published a powerful new piece by Chris Tilberis, who serves on OCRA’s Board of Directors, reflecting on his mother Liz Tilberis’ remarkable career as the former editor-in-chief … Continued

OCRA Champions Access and Equity in Ovarian Cancer and Gynecologic Cancer Awareness Month

As Ovarian and Gynecologic Cancer Awareness Month begins, Ovarian Cancer Research Alliance (OCRA) is proud to highlight a series of initiatives aimed at expanding access and promoting equity in ovarian and … Continued